Timeline
SkinBioTherapeutics
SkinBioTherapeutics said it's board has now completed its investigation
SkinBioTherapeutics says FRP forensic report imminent
SkinBioTherapeutics delays HY26 results as FRP forensic review continues on SkinBiotix platform
More in Biotech
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.